Biperiden
Back to searchMolecule Structure
Scientific Name
Biperiden
Description of the Drug
Biperiden is a muscarinic receptor antagonist used to treat parkinsonism and control extrapyramidal side effects of neuroleptic drugs.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00810
http://www.drugbank.ca/drugs/DB00810
Brand Name(s)
Akineton
Company Owner(s)
Abbvie Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL216 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL20229360 | SCHEMBL34957 | |
| PharmGKB | PA448626 | ||
| Human Metabolome Database | HMDB0014948 | ||
| DrugBank | DB00810 | ||
| PubChem: Thomson Pharma | 14752229 | ||
| PubChem | 2381 | ||
| LINCS | LSM-1235 | ||
| Nikkaji | J2.059A | ||
| BindingDB | 50240680 | ||
| EPA CompTox Dashboard | DTXSID6022680 | ||
| DrugCentral | 374 | ||
| Guide to Pharmacology | 7128 | ||
| rxnorm | BIPERIDEN | BIPERIDEN LACTATE | BIPERIDEN HYDROCHLORIDE |
| KEGG Ligand | C07941 | ||
| ChEBI | 3112 |
